One useful takeaway
- WHO recommends against weight-loss drugs and bariatric surgery for children under nine, prioritising lifestyle changes.
ARTICLE PREVIEW
Gist The World Health Organisation WHO has released comprehensive guidelines to manage the global surge in childhood and adolescent obesity. The core shift is a strong directive against using weight-loss drugs and bariatric surgery for children under nine, prioritising structured lifestyle interventions instead. For civil services aspirants, this marks a critical policy pivot in global public health, highlighting how the burden of non-communicable diseases NCDs is increasingly shifting to pediatric demographics and demanding immediate regulatory action in India. Background Obesity management in children historically lacked uniform global regulatory guardrails regarding pharmacological and surgical interventions. With the advent of new-generation weight-loss medications like GLP-1 receptor agonists , there has been a growing trend of medicalising childhood obesity to treat early-onset co-morbidities. The WHO acts as the primary directing and coordinating authority on international health within the UN system, and its guidelines serve as the baseline for national health policies. Key Pointers Age-based stratification: The WHO strongly opposes pharmacotherapy and bariatric surgery for children under nine, focusing exclusively on behaviour and diet, because invasive surgical procedures can permanently hamper natural physical growth.…
Checking your learner access…
We are securely restoring your session. The complete article will open automatically.